Jin Medical International Ltd. (NASDAQ:ZJYL – Get Free Report) saw a large decline in short interest in December. As of December 31st, there was short interest totaling 79,215 shares, a decline of 63.6% from the December 15th total of 217,828 shares. Based on an average daily trading volume, of 153,591 shares, the days-to-cover ratio is currently 0.5 days. Currently, 0.1% of the shares of the stock are short sold. Currently, 0.1% of the shares of the stock are short sold. Based on an average daily trading volume, of 153,591 shares, the days-to-cover ratio is currently 0.5 days.
Wall Street Analyst Weigh In
Separately, Weiss Ratings upgraded shares of Jin Medical International from a “sell (d)” rating to a “hold (c-)” rating in a report on Monday, December 29th. One research analyst has rated the stock with a Hold rating, According to MarketBeat.com, the company currently has an average rating of “Hold”.
Get Our Latest Stock Analysis on Jin Medical International
Jin Medical International Stock Down 0.2%
About Jin Medical International
Jin Medical International Ltd. engages in the design, development, manufacturing, and sale of wheelchair and other living aids products for people with disabilities or impaired mobility in China and internationally. It also offers oxygen concentrators and bathing machines. The company was founded in 2006 and is based in Changzhou, China. Jin Medical International Ltd. is a subsidiary of Jolly Harmony Enterprises Limited.
Read More
- Five stocks we like better than Jin Medical International
- Elon Taking SpaceX Public! $100 Pre-IPO Opportunity!
- How a Family Trust May Be Able To Help Preserve Your Wealth
- A U.S. “birthright” claim worth trillions – activated quietly
- Ticker Revealed: Pre-IPO Access to “Next Elon Musk” Company
- This stock gets a 94 out of 100
Receive News & Ratings for Jin Medical International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Jin Medical International and related companies with MarketBeat.com's FREE daily email newsletter.
